Collegium Pharmaceutical is committed to becoming the leader in responsible pain management. Our portfolio compels us to step into the pain market at a time when others have opted to step out. We recognize the importance of earning the trust of key stakeholders every day. We will continue to work hard to position Collegium to usher in a next generation of non-opioid pain solutions in the US market. We remain focused on making a positive difference in the lives of people suffering from pain and our communities.
The Director of Regional Accounts (DRA) will .
**** Persons applying for employment with Collegium Pharmaceutical on and after August 1, 2021, who are offered are expected to be able to provide proof of vaccination against COVID-19 prior to their start date as permitted under state law, unless they seek and are approved for an exemption by Collegium as a reasonable accommodation based on bona fide religious or medical grounds.